BioWorld

June 29, 2009

View Archived Issues

Clavis Turns Good Data into $20M Placement

Clavis Pharma AS cashed in on its recent success in the clinic by grossing NOK129 million (US$20.1 million) in a private placement directed at new and existing institutional shareholders. (BioWorld Today) Read More

7 Years Exclusivity Backed as a 'Generous Compromise'

Read More

Three Transcription Factors' Roles in Stem Cells Questioned

Read More

Arthritis: How Will it Impact the Biotech and Med-Tech Markets?

Read More

Corrections & Clarifications

Read More

Other News To Note

Read More